Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001241784 | SCV001414827 | pathogenic | not provided | 2023-02-16 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 966980). This premature translational stop signal has been observed in individual(s) with retinitis pigmentosa (PMID: 26787102). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Cys1008*) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). |
Ce |
RCV001241784 | SCV001502018 | pathogenic | not provided | 2020-07-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001828985 | SCV002808766 | pathogenic | Retinitis pigmentosa 25 | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001828985 | SCV002084431 | pathogenic | Retinitis pigmentosa 25 | 2021-03-22 | no assertion criteria provided | clinical testing |